E-LIB Suche - Ergebnisse für: Opat, A. S.

1

SALVAGE RADIOTHERAPY ASSOCIATES WITH DURABLE RESPONSE FOR A..:

Miller, J. H ; Gilbertson, M ; MacManus, M. P...
Hematological Oncology. 39 (2021) S2 - p. , 2021

Link: https://doi.org/10.1002/..

2

A retrospective study of the utility of desmopressin (1‐dea..:

Shortt, J. ; Opat, S. S. ; Gorniak, M. B....
International Journal of Laboratory Hematology. 32 (2010) 1p1 - p. , 2010

Link: https://doi.org/10.1111/..

3

The thrombotic thrombocytopenic purpura registry: a new nat..:

Polizzotto, M. N. ; Phillips, L. E. ; Cannell, P....
Internal Medicine Journal. 39 (2009) 1 - p. 72-73 , 2009

Link: https://doi.org/10.1111/..

4

A drop of vitriol: microspherocytosis following sulphuric a..:

Polizzotto, M. N. ; Shortt, J. ; Opat, S. S..
British Journal of Haematology. 140 (2008) 6 - p. 596-596 , 2008

Link: https://doi.org/10.1111/..

5

Failure of rituximab monotherapy in lymphomatoid granulomat..:

Polizzotto, M. N. ; Dawson, M. A. ; Opat, S. S.
European Journal of Haematology. 75 (2005) 2 - p. 172-173 , 2005

Link: https://doi.org/10.1111/..

6

MRD‐NEGATIVITY AFTER FRONTLINE DLBCL THERAPY: POOLED ANALYS..:

Roschewski, M. ; Kurtz, D. M. ; Westin, J....
Hematological Oncology. 41 (2023) S2 - p. 177-179 , 2023

Link: https://doi.org/10.1002/..

7

ZANUBRUTINIB (ZANU) VERSUS BENDAMUSTINE + RITUXIMAB (BR) IN..:

Shadman, M. ; Munir, T. ; Roback, T....
Hematological Oncology. 41 (2023) S2 - p. 235-238 , 2023

Link: https://doi.org/10.1002/..

8

Long‐term efficacy and safety of zanubrutinib (ZANU) in rel..:

Trotman, J. ; Tedeschi, A. ; Hu, B....
Hematological Oncology. 41 (2023) S2 - p. 390-392 , 2023

Link: https://doi.org/10.1002/..

9

POLATUZUMAB, BENDAMUSTINE & RITUXIMAB EFFICACY IN RELAPSED/..:

Shaw, B. ; Chung, E. ; Wellard, C....
Hematological Oncology. 41 (2023) S2 - p. 718-719 , 2023

Link: https://doi.org/10.1002/..

10

PHASE 1 STUDY OF JNJ‐67856633, A FIRST‐IN‐HUMAN MALT1 INHIB..:

Hertzberg, M. ; Kalac, M. ; Cheah, C. Y....
Hematological Oncology. 41 (2023) S2 - p. 131-132 , 2023

Link: https://doi.org/10.1002/..

11

P1609: VERY LOW MORTALITY IN DOUBLE VACCINATED IMMUNOCOMPRO..:

Shaw, B. ; Shortt, J. ; Rogers, B....
HemaSphere. 6 (2022) - p. 1490-1491 , 2022

Link: https://doi.org/10.1097/..

12

P1162: ZANUBRUTINIB IN OLDER PATIENTS (PTS) WITH RELAPSED/R..:

Opat, S. ; Hu, B. ; Tedeschi, A....
HemaSphere. 6 (2022) - p. 1049-1050 , 2022

Link: https://doi.org/10.1097/..

13

P1261: ALLG LABORATORY SCIENCE STUDY LS21: MOLECULAR CORREL..:

Tatarczuch, M. ; Waltham, M. ; Shortt, J....
HemaSphere. 6 (2022) - p. 1146-1147 , 2022

Link: https://doi.org/10.1097/..

14

P687: A PHASE 1 STUDY WITH THE NOVEL B-CELL LYMPHOMA 2 (BCL..:

Opat, S. ; Cheah, C. Y. ; Lasica, M....
HemaSphere. 6 (2022) - p. 583-584 , 2022

Link: https://doi.org/10.1097/..

15

P1161: ASPEN: LONG-TERM FOLLOW-UP RESULTS OF A PHASE 3 RAND..:

Dimopoulos, M. ; Opat, S. ; D'Sa, S....
HemaSphere. 6 (2022) - p. 1048-1049 , 2022

Link: https://doi.org/10.1097/..